# Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

> **NCT02270099** · — · COMPLETED · sponsor: **Hologic, Inc.** · enrollment: 839 (actual)

## Conditions studied

- Herpes Simplex Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02270099
- **Lead sponsor:** Hologic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-08
- **Final completion:** 2017-06
- **Target enrollment:** 839 (ACTUAL)
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02270099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02270099, "Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02270099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
